Show simple item record

dc.contributor.advisorKerin, Michael
dc.contributor.authorMurphy, Adrian David
dc.date.accessioned2015-11-25T09:52:59Z
dc.date.available2015-11-25T09:52:59Z
dc.date.issued2015-03-05
dc.identifier.urihttp://hdl.handle.net/10379/5348
dc.description.abstractIntroduction/Aim Ischemia Reperfusion injury is a poorly understood entity with wide-ranging clinical implications touching on most fields of clinical medicine. Using skin flap and hind limb models of injury in the mouse we attempt to reduce ischemia reperfusion injury by targeting different parts of the ischemia reperfusion injury pathway. Methods Dorsal lateral thoracic artery island skin flaps (3.5x1.5 cm) were elevated in C57BL/6 mice and rendered ischemic for 10 hours by placing a 7 mm microclamp on the vascular pedicle followed by 7 days of reperfusion. Hind-limb ischemia (was achieved with orthodontic rubber bands applied above the greater trochanter of male C57BL/6 mice using a McGivney Haemorrhoid Ligator. Limbs underwent ischemia for two hours followed by 24 hours reperfusion prior to euthanasia. Animals were treated with intravenous Poloxamer 188 and P8 IgM-binding protein to assess their effect on ischemiareperfusion injury. Results Administration of P188 prior to ischemia gave an average injury score of 8% which was significantly lower than the control group, injury score 55% (p<0.001). When administered just prior to reperfusion 12% injury was seen in the P188 group compared to 33% in the control group (p<0.001). Similarly when given two hours post-reperfusion P188 treated animals had 14% injury, compared to 38% injury in the control group (p<0.001). There was, however, no protection seen when treatment was given four hours post-reperfusion. In animals treated with P8 peptide, there was 14.61±2.77% flap necrosis. This represents a statistically significant 56% reduction in flap necrosis compared to controls (p<0.001). Conclusion Single dose P188 administered to animals undergoing hind-limb ischemia results in an increased myocyte survival rate following IR injury. This therapy is effective in pretreating animals as well as in a post-hoc, salvage role. We hypothesize that this effect is most likely due to P188 inserting into membrane defects and allowing membrane repair. This degree of protection from IR injury is comparable to the best results in other studies. P8 blockage of a specific IgM can protect against IR injury in an axial skin flap. This type of protection could be useful in improving results in free flap transfer and composite tissue transplantation.en_IE
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Ireland
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/3.0/ie/
dc.subjectIschemia reperfusion injuryen_IE
dc.subjectDepartment of Surgeryen_IE
dc.subjectSchool of Medicineen_IE
dc.titleAbrogation of ischemia reperfusion injury in murine hind limb and skin flap models of injuryen_IE
dc.typeThesisen_IE
dc.local.noteThis thesis investigates a number of treatment modalities aimed at reducing and/or reversing the effects of ischemia reperfusion injury. The original research work uses mouse models of skeletal muscle and systemic injury (hind-limb model) and skin (skin flap model). End points used include degree of muscle death, degree of skin death, muscle ATP levels as well as animal survivalen_IE
dc.local.finalYesen_IE
nui.item.downloads239


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Ireland
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland